OXYGENATION

Legal Notice

  • Copyright 2023 Assessment Technologies Institute, L.L.C. All rights reserved.

  • This material is the sole property of Assessment Technologies Institute, L.L.C. ("ATI") and is licensed for use by ATI's clients in nursing programs utilizing ATI Engage resources.

  • Restrictions on use include:

    • Posting on institution’s Learning Management System (LMS) with copyright notices.

    • Use is institutional rather than personal; any termination of the license results in the immediate cessation of rights to use this material.

    • No sharing outside the institution or posting on social media.

Learning Objectives

  1. Pathophysiology of COPD, Asthma, and RSV

    • Differentiate the underlying conditions and their impacts on ventilation, diffusion, and perfusion. (Analysis)

  2. Advanced Oxygenation Assessment Data Interpretation

    • Analyze data from lung sounds, arterial blood gases (ABGs), pulse oximetry trends, work of breathing, and patient history. (Analysis)

  3. Prioritize Nursing Interventions

    • Address oxygenation impairment in patients with COPD, asthma, or RSV using the Clinical Judgment Model. (Analysis → Application)

  4. Implement Evidence-Based Interventions

    • Optimize oxygenation practices including positioning, oxygen therapy titration, airway clearance techniques, and medication use. (Application)

  5. Develop Educational Plans

    • Create individualized plans for patients and families on disease management, trigger avoidance, and when to seek care. (Application)

  6. Collaborate with Healthcare Team

    • Work with respiratory therapy and other team members for coordinated care of patients with oxygenation needs. (Application)

  7. Evaluate Patient Responses

    • Analyze respiratory status trends and adjust care plans accordingly. (Evaluation)

  8. Apply Safety Principles

    • Prevent complications like oxygen toxicity and monitor specific risks in COPD and RSV patients. (Evaluation)

Chronic Obstructive Pulmonary Disease (COPD)

General Overview

  • Includes conditions like chronic bronchitis and emphysema.

  • Results from chronic bronchitis (mucus hypersecretion and airway inflammation) and emphysema (alveolar destruction).

Pathophysiology

  • Chronic bronchitis: Airway inflammation leading to mucus production, airflow limitation, ventilation/perfusion (V/Q) mismatch.

  • Emphysema: Destruction of alveolar walls, loss of elastic recoil, leading to air trapping and diffusion impairment.

Causes & Risk Factors

  • Exposure to cigarette smoke and occupational hazards.

  • Epidemiological links to smoking and pollutant exposure.

Clinical Presentation

  • Manifestations:

    • Exertional dyspnea, chronic cough with sputum production.

    • Wheezing, chest tightness, barrel chest, and weight loss in advanced stages.

  • Lab Testing & Diagnostics:

    • Spirometry assessment; use of CAPTURE questionnaire for symptom evaluation.

CO2 Concentration Monitoring

  • Capnography Monitoring:

    • Reflects lung CO2 elimination, tissue CO2 production, circulatory CO2 transport.

    • Normal EtCO2 values: 35-45 mmHg.

  • Abnormal Waveforms & Clinical Significance:

    • Elevated baseline suggests rebreathing; other abnormalities indicate various clinical issues.

Treatment Overview

  • Chronic Bronchitis:

    • Focus on smoking cessation, bronchodilators, inhaled steroids, mucolytics, and oxygen therapy.

  • Emphysema:

    • Include bronchodilators, pulmonary rehab, and potential surgical interventions.

  • Key Differences:

    • Chronic bronchitis is a ventilation problem; emphysema primarily affects diffusion.

Overview of COPD Inhaled Medications

  • Categories and examples:

    • Short-Acting Bronchodilators: Provide rapid relief.

    • Long-Acting Bronchodilators: Used for maintenance therapy.

    • Combination Inhalers: ICS/LABA, LAMA/LABA for tailored therapy.

    • Inhalers include brands like Advair® Diskus®, Spiriva® Handihaler®, and others listed with their active ingredients and dosing specifics.

Asthma

Pathophysiology

  • Characterized by airway inflammation and bronchospasm.

  • Normal diffusion and perfusion; acute ventilation/perfusion mismatch.

  • Risk factors linked to tobacco smoke, common in developed countries.

Clinical Presentation

  • Manifestations:

    • Wheezing, cough (mucous or dry), chest tightness, dyspnea.

  • Lab Testing and Risk Assessment:

    • Diagnostic tools include ABGs, ECG, CXR, and chest CT scans; recognize RED Zone from peak flow meter readings in emergencies.

  • Pediatric Warning Signs:

    • Observe signs like poor feeding, decreased activity, and sudden quietness.

Overall Health Impact

  • Asthma can lead to physiological and psychosocial consequences such as increased fatigue, anxiety, absenteeism from school/work, and medication sensitivity in older adults.

Role of the Nurse

  • Manage environmental factors and patient education.

  • Establish treatment regimes including behavior modification, peak flow meter training, and collaborative care.

  • Applying the Nursing Process to assess and evaluate outcomes systematically.

Respiratory Syncytial Virus (RSV)

Pathophysiology

  • Infection results in airway epithelial cell swelling; leads to edema and mucus overproduction, causing ventilation issues and hypoxia.

Clinical Manifestations

  • Early Symptoms: Rhinorrhea, mild cough, low-grade fever, decreased appetite.

  • Severe Symptoms: Wheezing, tachypnea, nasal flaring, intercostal retractions, apnea in infants.

Diagnostic Laboratory Tests

  1. Reverse Transcription-PCR (gold standard).

  2. Rapid Antigen Detection Test.

  3. Viral Culture and Serology for antibodies.

  4. Supportive diagnostics: chest X-ray, pulse oximetry, ABGs.

Treatment Approach

  • Focus on airway management, oxygen therapy, hydration, and comfort, with specific indications for antivirals in severe cases.

  • Prevention strategies include the use of Palivizumab.

Advanced Oxygenation Assessment

Assessment Parameters

  • Early Signs and Worsening Signs:

    • Lung sounds and ABGs indicating changes in respiratory status, such as mild wheezes indicating early signs and diffuse wheezes (silent chest) indicating severe deterioration.

    • Rely on pulse oximetry for target saturation levels and note changes in work of breathing.

Interventions for Oxygenation

Key Interventions

  • Positioning: High Fowler’s, tripod stance for improved ventilation.

  • Oxygen Therapy: Target SpO₂ for COPD (88-92%) and general cases (92-100%).

  • Airway Clearance: Techniques include suctioning.

  • Medications: Use bronchodilators and corticosteroids based on clinical judgment.

Patient & Family Education

  • Emphasize understanding triggers, monitoring symptoms, and proper inhaler techniques.

  • Discuss necessary lifestyle changes to prevent exacerbations and when to seek care.

Collaboration and Role in Care Coordination

  • Importance of communication regarding respiratory status changes, timely escalations of care for severe cases, and documentation of trends in interventions.

Evaluation and Trend Analysis

Indicators of Improvement

  • Look for improvements in SpO₂, decreases in work of breathing, and normalization in ABG results.

Indicators for Reassessment

  • Increased respiratory rates, decreased SpO₂, and poor bronchodilator responses signal the need for reevaluation.

Safety Principles in Respiratory Treatment

  • Monitor for potential oxygen toxicity in patients on high flow systems, and ensure adherence to adequate dosing and timing for medications. Maintain equipment rigor, checking oxygen delivery systems and suctioning devices effectively.

Learning Objectives

  1. Pathophysiology of COPD, Asthma, and RSV

    • Differentiate the underlying conditions and their impacts on ventilation, diffusion, and perfusion. This includes understanding the physiological changes that occur during exacerbations and the chronic nature of the diseases. It also covers the varying responses to environmental triggers that can worsen symptoms.

  2. Advanced Oxygenation Assessment Data Interpretation

    • Analyze and interpret data from lung sounds, arterial blood gases (ABGs), pulse oximetry trends, work of breathing, and patient history to determine hypoxemia and hypercapnia. Understanding the implications of various ABG levels is essential for effective treatment.

  3. Prioritize Nursing Interventions

    • Address oxygenation impairment in patients with COPD, asthma, or RSV using the Clinical Judgment Model to evaluate situations critically and implement timely interventions that address immediate needs and long-term management.

  4. Implement Evidence-Based Interventions

    • Optimize oxygenation practices, including precise positioning (High Fowler’s), judicious titration of oxygen therapy, effective airway clearance techniques, and strategically administered medications to provide holistic care.

  5. Develop Educational Plans

    • Create individualized education plans for patients and families focusing on self-management strategies, understanding disease triggers, recognizing worsening symptoms, and knowing when to seek care to enhance overall quality of life and reduce hospitalizations.

  6. Collaborate with Healthcare Team

    • Actively work in collaboration with respiratory therapy, pulmonologists, and other healthcare professionals to ensure coordinated and comprehensive care for patients with complex oxygenation needs. Regular interdisciplinary meetings can enhance team communication and information sharing.

  7. Evaluate Patient Responses

    • Continuously assess respiratory status trends through objective and subjective data, recognizing patterns that necessitate adjustments in care plans, thereby enhancing patient outcomes and personalizing treatment approaches.

  8. Apply Safety Principles

    • Proactively prevent complications such as oxygen toxicity and develop protocols to monitor and manage specific risks inherent in COPD and RSV patients, such as device malfunctions and medication side effects.

Chronic Obstructive Pulmonary Disease (COPD)
General Overview

  • COPD encompasses a group of progressive lung diseases, predominantly chronic bronchitis and emphysema, which lead to difficulty in breathing due to airflow blockage.

  • The management of COPD requires a multifaceted approach involving pharmacological treatment, lifestyle modifications, and supportive care, particularly during exacerbations.

Pathophysiology

  • Chronic bronchitis is characterized by chronic inflammation of the bronchial tubes, causing mucus overproduction and leading to airflow obstruction and ventilation/perfusion (V/Q) mismatch due to blocked airways.

  • Emphysema involves the breakdown of alveolar walls, resulting in diminished elastic recoil, destruction of gas exchange surfaces, air trapping, and further diffusion impairment, leading to hypoxemia and potential respiratory failure.

Causes & Risk Factors

  • Principal causes include long-term exposure to cigarette smoke, environmental pollutants, chemical fumes, and occupational dust, with genetic factors like Alpha-1 antitrypsin deficiency also playing a critical role in some cases.

Clinical Presentation

  • Manifestations:

    • Patients typically experience exertional dyspnea, a chronic productive cough with sputum, wheezing, chest tightness, and in severe cases, barrel chest and weight loss due to increased work of breathing.

  • Lab Testing & Diagnostics:

    • Diagnostic evaluations include spirometry, which is crucial for confirming diagnosis and assessing severity, the use of the CAPTURE questionnaire for symptom evaluation, and chest X-rays to rule out other conditions.

CO2 Concentration Monitoring

  • Capnography Monitoring:

    • This crucial assessment reflects the efficiency of CO2 elimination and can indicate respiratory distress. It is important to recognize normal and abnormal EtCO2 values during clinical examinations.

  • Abnormal Waveforms & Clinical Significance:

    • Abnormal patterns in capnography, such as elevated baseline levels, can suggest rebreathing or complications like acute respiratory distress, providing essential information for timely interventions.

Treatment Overview

  • Chronic Bronchitis Treatment:

    • Emphasis on smoking cessation, lifestyle modifications, bronchodilators to relieve obstruction, inhaled corticosteroids to reduce inflammation, mucolytics to assist in mucus clearance, and supplemental oxygen when needed.

  • Emphysema Management:

    • Involves bronchodilators, comprehensive pulmonary rehabilitation programs focused on physical conditioning, and consideration for surgical options like lung volume reduction surgery in severe cases.

  • Key Differences:

    • Clinically, chronic bronchitis tends to present with significant airway obstruction and mucus buildup, while emphysema is characterized by marked diffusion impairment and air trapping, leading to different management strategies in clinical practice.

Overview of COPD Inhaled Medications

  • Categories and examples:

    • Short-Acting Bronchodilators: Side effects to be monitored; these provide user-friendly rapid relief during acute attacks.

    • Long-Acting Bronchodilators: Essential for daily maintenance therapy; dose adjustments should be tailored based on patient response.

    • Combination Inhalers: ICS/LABA, LAMA/LABA, allow for tailored therapy based on individual patient needs, requiring nursing education for effective usage.

    • Notable inhalers include Advair® Diskus®, Spiriva® Handihaler®, illustrating a wide range of active ingredients and dosing specifications tailored for diverse patient populations.